<VariationArchive VariationID="1897839" VariationName="NM_001754.5(RUNX1):c.285del (p.Asn96fs)" VariationType="Deletion" Accession="VCV001897839" Version="4" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-07-29" DateCreated="2023-02-07" MostRecentSubmission="2024-07-29">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1959813" VariationID="1897839">
      <GeneList>
        <Gene Symbol="RUNX1" FullName="RUNX family transcription factor 1" GeneID="861" HGNC_ID="HGNC:10471" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>21q22.12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="21" Accession="NC_000021.9" start="34787801" stop="35049302" display_start="34787801" display_stop="35049302" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="21" Accession="NC_000021.8" start="36160097" stop="36421594" display_start="36160097" display_stop="36421594" Strand="-" />
          </Location>
          <OMIM>151385</OMIM>
          <Haploinsufficiency last_evaluated="2023-06-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RUNX1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2023-06-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RUNX1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001754.5(RUNX1):c.285del (p.Asn96fs)</Name>
      <CanonicalSPDI>NC_000021.9:34886908:GGGG:GGG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>21q22.12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="21" Accession="NC_000021.9" start="34886909" stop="34886909" display_start="34886909" display_stop="34886909" variantLength="1" positionVCF="34886908" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="21" Accession="NC_000021.8" start="36259206" stop="36259206" display_start="36259206" display_stop="36259206" variantLength="1" positionVCF="36259205" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
      </Location>
      <OtherNameList>
        <Name>NM_001754.5(RUNX1):c.285del</Name>
        <Name>p.Asn96fs</Name>
      </OtherNameList>
      <ProteinChange>N69fs</ProteinChange>
      <ProteinChange>N96fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000021.8" sequenceAccession="NC_000021" sequenceVersion="8" change="g.36259209del" Assembly="GRCh37">
            <Expression>NC_000021.8:g.36259209del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000021.9" sequenceAccession="NC_000021" sequenceVersion="9" change="g.34886912del" Assembly="GRCh38">
            <Expression>NC_000021.9:g.34886912del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011402.2" sequenceAccession="NG_011402" sequenceVersion="2" change="g.1102803del">
            <Expression>NG_011402.2:g.1102803del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_144242.1" sequenceAccession="NG_144242" sequenceVersion="1" change="g.387del">
            <Expression>NG_144242.1:g.387del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001001890.3" sequenceAccession="NM_001001890" sequenceVersion="3" change="c.204del">
            <Expression>NM_001001890.3:c.204del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001001890.1" sequenceAccession="NP_001001890" sequenceVersion="1" change="p.Asn69fs">
            <Expression>NP_001001890.1:p.Asn69fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001122607.2" sequenceAccession="NM_001122607" sequenceVersion="2" change="c.204del">
            <Expression>NM_001122607.2:c.204del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001116079.1" sequenceAccession="NP_001116079" sequenceVersion="1" change="p.Asn69fs">
            <Expression>NP_001116079.1:p.Asn69fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001754.5" sequenceAccession="NM_001754" sequenceVersion="5" change="c.285del" MANESelect="true">
            <Expression>NM_001754.5:c.285del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001745.2" sequenceAccession="NP_001745" sequenceVersion="2" change="p.Asn96fs">
            <Expression>NP_001745.2:p.Asn96fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_482" sequenceAccession="LRG_482">
            <Expression>LRG_482:g.1102803del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_482t1" sequenceAccession="LRG_482t1">
            <Expression>LRG_482t1:c.282del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_482p1" sequenceAccession="LRG_482p1" change="p.Asn96Thrfs">
            <Expression>LRG_482p1:p.Asn96Thrfs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001754.5(RUNX1):c.285del (p.Asn96fs) AND Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1" Accession="RCV002573638" Version="2">
        <ClassifiedConditionList TraitSetID="3994">
          <ClassifiedCondition DB="MedGen" ID="C1832388">Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-08-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001754.5(RUNX1):c.285del (p.Asn96fs) AND Hereditary thrombocytopenia and hematologic cancer predisposition syndrome" Accession="RCV004595667" Version="1">
        <ClassifiedConditionList TraitSetID="54065">
          <ClassifiedCondition DB="MedGen" ID="CN281654">Hereditary thrombocytopenia and hematologic cancer predisposition syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>reviewed by expert panel</ReviewStatus>
            <Description DateLastEvaluated="2024-03-26" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-26" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2023-02-07" MostRecentSubmission="2024-07-29">
        <ReviewStatus>reviewed by expert panel</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">18723428</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24100448</ID>
        </Citation>
        <Citation Type="general">
          <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/f751a626-31e6-4fb0-b9a0-7428b6bf7c21</URL>
        </Citation>
        <ConditionList>
          <TraitSet ID="54065" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="53344" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hereditary thrombocytopenia and hematologic cancer predisposition syndrome</ElementValue>
                <XRef ID="MONDO:0011071" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10352" />
                <XRef ID="10352" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="71290" DB="Orphanet" />
              <XRef ID="CN281654" DB="MedGen" />
              <XRef ID="MONDO:0011071" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3994" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="3980" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Platelet disorder, Aspirin-like</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial Platelet Disorder with Propensity to Acute Myelogenous Leukemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial platelet disorder with associated myeloid malignancy</ElementValue>
                <XRef ID="Familial+Platelet+Disorder+with+Associated+Myeloid+Malignancy/2765" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial thrombocytopenia with propensity to acute myelogenous leukemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1</ElementValue>
                <XRef ID="MONDO:0100083" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">FPDMM</ElementValue>
                <XRef Type="MIM" ID="601399" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">FPD/AML</ElementValue>
                <XRef Type="MIM" ID="601399" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">RUNX1 familial platelet disorder with associated myeloid malignancies (RUNX1-FPDMM) is characterized by prolonged bleeding and/or easy bruising and an increased risk of developing a hematologic malignancy. RUNX1-FPDMM is characterized by thrombocytopenia with normal platelet size; bleeding is often greater than expected due to qualitative platelet dysfunction. Myeloid malignancies are the most common, including acute myelogenous leukemia (and myelodysplastic syndrome. T- and B-cell acute lymphoblastic leukemias and lymphomas have also been reported, as well as skin manifestations (e.g., eczema, psoriasis).</Attribute>
                <XRef ID="NBK568319" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15329" />
                <XRef ID="15329" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">33661592</ID>
                <ID Source="BookShelf">NBK568319</ID>
              </Citation>
              <XRef ID="71290" DB="Orphanet" />
              <XRef ID="C1832388" DB="MedGen" />
              <XRef ID="C563324" DB="MeSH" />
              <XRef ID="MONDO:0100083" DB="MONDO" />
              <XRef Type="MIM" ID="601399" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5625109" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="11949325|MedGen:C1832388" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002933115" DateUpdated="2024-02-28" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">18723428</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24100448</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with RUNX1-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Asn96Thrfs*26) in the RUNX1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RUNX1 are known to be pathogenic (PMID: 18723428, 24100448).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RUNX1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000021.8:g.36259206del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1832388" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion FDARecognizedDatabase="true" ID="9877724" SubmissionDate="2024-07-17" DateLastUpdated="2024-07-29" DateCreated="2024-07-29">
        <ClinVarSubmissionID localKey="f751a626-31e6-4fb0-b9a0-7428b6bf7c21" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV005088345" DateUpdated="2024-07-29" DateCreated="2024-07-29" Type="SCV" Version="1" SubmitterName="ClinGen Myeloid Malignancy Variant Curation Expert Panel" OrgID="507107" OrganizationCategory="consortium" OrgAbbreviation="MyeloMalig_VCEP" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-26">
          <ReviewStatus>reviewed by expert panel</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/f751a626-31e6-4fb0-b9a0-7428b6bf7c21</URL>
          </Citation>
          <Comment>The NM_001754.5(RUNX1):c.285del (p.Asn96ThrfsTer26) is a frameshift variant in a gene in which loss-of-function is an established mechanism (Frameshift (+1); c.98-c.779 as per VCEP specifications) (PVS1). This variant affects one of the amino acid residues between 89-204 within the RHD (PM1_supporting). This variant is completely absent from all population databases with at least 20x coverage for RUNX1 (PM2_Supporting). This frameshift variant is downstream of c.98 in transcript NM_001754.4 (PM5_Supporting). In summary, this variant meets the criteria to be classified as pathogenic. ACMG/AMP criteria applied, as specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: PVS1, PM1_supporting, PM2_supporting, PM5_supporting.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ClinGen MyeloMalig ACMG Specifications v2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/g9fkgwq9/clingen_myelomalig_acmg_specifications_v2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RUNX1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_001754.5(RUNX1):c.285del</Name>
            <Name>p.Asn96fs</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000021.9:g.34886912del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0011071" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14608106</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5625109" TraitType="Disease" MappingType="XRef" MappingValue="C1832388" MappingRef="MedGen">
        <MedGen CUI="C1832388" Name="Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9877724" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0011071" MappingRef="MONDO">
        <MedGen CUI="CN281654" Name="Hereditary thrombocytopenia and hematologic cancer predisposition syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

